Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Flash card on congenital heart diseases
Flash card on congenital heart diseases
Flash card on congenital heart diseases
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Flash card on congenital heart diseases
Background: Although ventricular septal defect (VSD) is the most common congenital heart disease, it is usually diagnosed late. The image of the disease is variable; sometimes it is so quit and silent that might even be healed and be improved spontaneously, and in some certain cases if the appropriate, on time and early treatment is not be done, this would lead to irreparable complications even in the early life period such as mortality. This study aimed to study, review and the way of diagnosis process, treatment and follow-up of these patients. It is hoped that the results of the present study be used in order for improving the patient’s condition.
Methods: This was a cross-sectional study done on 145 patients with VSD during 54 months in Isfahan. The required data collected at the time of definite diagnosis by taking their history. The disease was identified through Color Doppler echocardiogram, and cardiac catheterization and angiography if necessary.
Results: The average age of the initial diagnosis of the disease was at 17 months old and average age of the definite diagnosis was at 44 months old. The initial diagnosis in 85% of the cases was associated with heart murmur. In 27.5% of the cases, VSD had been associated with other cardiac anomalies. Pulmonary artery hypertension was observed in 16.5% of the cases. Fifty nine surgeries were performed on 40 patients.
Conclusion: In routine and daily examination of the infants, the probability of heart disease should be considered; conducting echocardiogram and cardiac consultation in the suspected cases would lead to early diagnosis and eventually the timely treatment. Appropriate follow-up of the patients will cause providing the optimal care and treatment services at the r...
... middle of paper ...
...s and ultimately treatment of the heart disease.
3. Considering the possibility of additional cardiac anomalies and also pulmonary artery hypertension would provide optimal care and treatment services at the right time.
References
…
Table1: The type of VSD and additional cardiac anomalies, pulmonary artery hypertension (PAH), the number and age of the surgery in the studied patients.
type of VSD Number (percent) PAH No. (%) Surgery No. (%) Age of surgery (month)
Single VSD 105 (72.5) 8 (7.6) 15 (14) 45 ± 22
VSD with additional cardiac anomalies 40 (27.5) 16 (40) 19 (47.5) 37 ± 14
Patent ductus arteriosus 20 (50) 11 (55) 19 (95) 10 ± 3
Patent ductus arteriosus with aortic coarctation 6 (15) 5 (83) 5 (83) 10 ± 3
Atrial perforation 5 (12.5) - 1 (20) 44 ± 29
Pulmonary artery stenosis 9 (22.5) - -
Bacterial endocarditis 1 (0.7)
Mortality 2 (1.4)
The facts in this case involve 2 patients. Firstly, Marguerite, an 89 year old female who experienced a myocardial infarction and the cause was unknown at the time of admission. Her doctor ordered an angiogram to test for the cause, and based on the results, would plan and provide treatment. On the other hand, Sarah, a 45 year old female, also experienced a massive heart attack, but in her case the emergency room doctors were able to determine the cause and expeditiously planned for treatment. Simultaneously, both patients required an immediate surgical procedure and time was a major consideration due to the nature of their
“Ebstein’s anomaly is a rare cardiac anomaly that occurs in approximately one in 20,000 live births and accounts for less than 1% of all congenital heart disease (Ebstein’s anomaly in adults)”. The goal of this paper is to examine Ebstein’s Anomaly - to understand what it is, how it affects the heart, possible presenting symptoms, and other possible complications associated with this anomaly. Diagnosis of this anomaly is key in treating patients, thus echocardiographic as well as other test modalities are vital in assessing what the treatment options are available, as well as discerning what the prognosis may be. Advancing test modalities have helped distinguish Ebstein’s Anomaly with other differential diagnoses. Developments with testing modalities coupled with comprehensive calculations, formulas, and measurements have facilitated correctly diagnosing, and therefore properly treating cardiac patients.
“Hypoplastic left heart syndrome accounts for 9% of all critically ill newborns with congenital cardiac disease, causing the largest number of cardiac deaths in the first year of life.(2) ” HLHS is a severe heart defect that is present at birth. HLHS combines different defects that result in an underdeveloped left side of the heart. This syndrome is one of the most challenging and difficult to manage of all of the congenital heart defects. Multiple portions on the left side of the heart are affected including the left ventricle, the mitral and aortic valve, and the ascending aorta. These structures are greatly reduced in size, or completely nonexistent causing the functionality of the left heart to be reduced, or non-functional all together.
There are four different categories of treatment: lifestyle changes, surgical procedures, non-surgical procedures, and medications. Lifestyle changes include having a healthy diet; increasing physical activity; eliminating cigarettes, alcoholic beverages, and illicit drugs; and getting enough rest and sleep; losing excess weight. These lifestyle changes are to lower the patient’s blood pressure, cholesterol, and reducing any other future medical conditions. There are also surgical options to help cure, prevent, or control cardiomyopathy. Surgical method include a septal myectomy, surgically implanted devices, and a heart transplant. A septal myectomy is used to specifically treat hypertrophy cardiomyopathy which is where the heart muscle cells enlarge and cause the walls of the ventricles to thicken. The thickening of the walls may not affect the size of the ventricles but instead may affect the blood flow out of the ventricle. Usually along with the ventricles swelling, the septum in between the ventricles can become enlarged and block the blood flow causing a heart attack. When medication is not working well to treat hypertrophic cardiomyopathy, a surgeon will open the chest cavity and remove part of the septum that is blocking blood flow. Surgically implanted devices include a pacemaker, a cardiac resynchronization therapy device, a left ventricular assist device, and an implantable
... Various treatment modalities have been described, including lobectomy or segmentectomy, systemic artery to pulmonary artery anastomosis and endovascular treatment. Differentiation between this condition from classic sequestration has important treatment implications as it may allow non-operative management (angiographic embolization) of the aberrant systemic artery.
The Burden of the disease is high with a prevalence of 3.4% 2. With the progressive nature of the disease and the increased severity of the symptoms made the surgery the gold standard for symptomatic AS patients ,however up to 30% of cases are considered too high risk for classical valve replacement surgery and remain untreated and experiencing poor prognosis . Fortunately , with the introduction of TAVR its offer a valuable option for the inoperable or at high risk of surgery patients3..the annual eligible candidate for this procedure expected to be 27,000 in 19 European countries and North America according to recent meta-analysis an...
For example, heart and lung transplants. This is a solution if a patient’s hole in the heart cannot be healed or helped with another form treatment. Several different targeted therapies have been done to improve health of ES patients. Disease-targeting therapies have proven to be successful in Idiopathic Pulmonary Arterial Hypertension (IPAH) and have been analyzed to in their effectiveness against ES. Prostanoid therapy in patients with ES has also shown the possibility that therapy may improve oxygen saturation, exercise capacity, and even shows a decrease Pulmonary Vascular Resistance (PVR). This is backed by a study with eight patients that have ES, these results were after 3 months of therapy. Another study is being done in a method called Vasodilator therapy. In these case studies, a drug name prostacyclin improved hemodynamics sufficiently enough to ensure ES patients for surgery to repair the cardiac lesion. Other studies have shown that Phosphodiesterase Type-5 Inhibitors, were used in patients with ES. In these studies, observation over a six-month period allowed the researchers to see improvements in oxygen saturation and cardiopulmonary hemodynamics (Beghetti and Galiè, 2009). Research from these studies is also being combined with different medical treatment to target therapies and is it possible to reverse pulmonary vascular
During a physical examination, a specialist may hear a heart murmur which will prompt a referral to a pediatric cardiologist for an analysis. Diagnostic testing will vary by the child’s age, clinical condition, and institutional preferences. Such test may incorporate a chest X-ray, electrocardiogram, echocardiography and cardiac catheterization. A chest X-ray uses unseen X-ray beams to cr...
The purpose of this paper is to establish an understanding of the rare heart disease Tetralogy of Fallot. Tetralogy of Fallot is a congenital heart defect that is present at birth, with the structure of the heart being problematic. It changes the normal flow of blood through the heart. The aspects of it being explained are the overall disease and symptoms of it. Secondly, the long term and short term effects corresponding to the particular disease. Lastly, the causes, prevention, and statistics of the disease. This research will provide an insight to the disease and all aspects and forms. It will allow a better understanding on how to cope with such disease or better prepare us in a case where this disease may be present and have to be dealt with.
The primary concern for Mr. Miller would be preventing further ischemia and necrosis of the myocardial tissues, preventing serious complications such as cardiac dysrhythmias and heart failure, as well as relieving his chest pain that radiates to his left arm. Preventing further ischemia and necrosis of the myocardial tissue will help prevent the development of heart failure due to myocardial infarction, whereas relieving his pain will help reduce his episodes of shortness of breath, and will also help to reduce any anxiety and restlessness he may be having from being in pain and short of breath.
In conclusion, the specifics of Sudden Infant Death Syndrome are not very well known. Even today, research is still being carried out to determine the exact cause of this silent disease. Until that time comes, the public must rely on preventative tips in order to reduce the frequency of this disease infiltrating more families.
The commonest defect is a narrowing of the main artery from the heart aortic coarctation. A regular ultrasound examination of the heart ... ... middle of paper ... ... s are relatively limited. So far, researchers think it will be possible to increase the final height by 5-10 centimeters, depending on the duration of treatment.
Cardiovascular System: He does not experience any chest pain or palpitation. He does not have dyspnea or leg swelling.
Client Profile: Lane Bronson is a 55 year old male with a history of angina, hypertension, Type 2 diabetes, COPD, and sleep apnea. He comes to the physican’s office complaining of worsening shortness of breath. His skin tone is grey, and his angina is worsening. Previously stable, he now does not get relief from rest or nitroglycerin. The physician called 911 and had Mr. Bronson directly admitted to the hospital.
...itoring vital signs in infants, children and young people [WWW] RCN . Available from http://www.rcn.org.uk/__data/assets/pdf_file/0004/114484/003196.pdf [Accessed 26/03/2013].